 |
Headache
We treat patients with chronic debilitating headaches and conduct research on promising headache treatments. Along with drug treatments, we offer treatments including education, relaxation techniques, biofeedback, and stress management.
Types of Headaches
Each year, more than 45 million Americans suffer from chronic, severe headaches, including approximately 28 million who suffer from migraines.
There are two main types of headaches.
Primary headaches are headaches that do not result from another medical condition. They include tension, migraine and cluster headaches.
Secondary headaches result from another medical condition such as sinus problems, hormone imbalances, injury or tumor.
Diagnosis and Treatment
Because medical science has identified more than 150 diagnostic categories for headaches, appropriate diagnosis is critical to successful treatment. Once properly diagnosed, chronic headaches such as migraine or cluster headaches can respond well to treatment. Headaches resulting from secondary causes require prompt and accurate diagnosis so that the underlying cause can be treated.Our comprehensive neuro-imaging diagnostic capabilities include CT and MRI, and our treatment capabilities include infusion therapy.
Learn more about headache
National Headache Foundation
www.headaches.org
American Headache Society
www.americanheadachesociety.org
American Headache Society Committee for Headache Education
www.achenet.org
Physicians
Laszlo L. Mechtler, MD.
Minsoo Kang, M.D.
|
|
Research/Clinical Trials
Sponsor: OrthoMcneil Pharmaceuticals Inc.
Study: CAPSS 334
PI: Laszlo Mechtler, M. D.
Description: Efficacy of AXERT® (Almotriptan Malate) in the Acute Treatment of Migraine: A Pilot Study of the Potential Impact of Preventive Therapy with TOPAMAX® (Topiramate) -
39 Patients
Sponsor: OrthoMcneil Pharmaceuticals Inc.
Study: CAPSS 381
PI: Laszlo Mechtler, M. D.
Description: Topiramate Intervention to Prevent Transformation of EPIsoDic Migraine: The Topiramate INTREPID Study - 11 patients
Sponsor: St. Jude’s Medical
Study: Escape
PI: Laszlo Mechtler, M. D.
Description: Effect of Septal Closure of Atrial PFO on Events of migraine with eh PREMERE device- ESCAPE - September 2007
Sponsor: UCB Pharma. Inc.
Study: TBA
PI: Laszlo Mechtler, M. D.
Description: Treatment of Acute Migraine Headache with Intravenous Levetiracetam: Initial Outpatient Experience - 3 patients
Sponsor: GSK Inc.l
Study: GSK Study TRX10657
PI: Laszlo Mechtler, M. D.
Description: TRX106573 A Study of Combination Product (sumatriptan succinate and naproxen sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans - 8 patients
Sponsor: GSK Inc.l
Study: GSK Study TXA107977
PI: Laszlo Mechtler, M. D.
Description: A Long-Term Safety Study of a Combination Product Containing Sumatriptan Succinate and Naproxen Sodium for the Treatment of Migraine in Adolescents -
September 2007
Sponsor: Merck & O.
Study: MK 0974-016
PI: Laszlo Mechtler, M. D.
Description: A Phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Oral MK-0974 in the Acute Treatment of Migraine With or Without Aura - 16 patients
Sponsor: Merck & O.
Study: MK 0974-012
PI: Laszlo Mechtler, M. D.
Description: A Multicenter, Double-Blind, Active- Controlled, Parallel Group Study to Examine The Safety, Tolerability and Efficacy of Oral MK-0974 for the Long Term Treatment of Acute Migraine with or without Aura - 2 patients
|
|
